Advertisement
Satsuma Pharmaceuticals I... (STSA)
NASDAQ: STSA
· Real-Time Price · USD
1.10
0.00 (0.00%)
At close: Jun 07, 2023, 8:00 PM
Company Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines.
The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device.
Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Satsuma Pharmaceuticals Inc.
| Country | United States |
| IPO Date | Sep 13, 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 25 |
| CEO | John A. Kollins MBA |
Advertisement
Contact Details
Address: 400 Oyster Point Boulevard South San Francisco, California United States | |
| Website | https://www.satsumarx.com |
Stock Details
| Ticker Symbol | STSA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001692830 |
| CUSIP Number | 80405P107 |
| ISIN Number | US80405P1075 |
| Employer ID | 81-3039831 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| John A. Kollins MBA | Pres, Chief Executive Officer & Director |
| Thomas P. O'Neil | Chief Financial Officer |
| Dr. Detlef F. Albrecht | Chief Medical Officer |
| Dr. Shannon Strom Ph.D. | Vice President & Head of Regulatory Affairs |
| Mic Iwashima | Vice President & Head of Operations |
| Robert Schultz | Senior Vice President & Head of Chemistry, Manufacturing and Controls |
| Robert M. Janosky | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 20, 2023 | 15-12G | Filing |
| Jun 12, 2023 | 4 | Filing |
| Jun 13, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jun 12, 2023 | SC 13D/A | [Amend] Filing |
| Jun 08, 2023 | 4 | Filing |
| Jun 08, 2023 | 4 | Filing |
| Jun 08, 2023 | 4 | Filing |
| Jun 08, 2023 | 4 | Filing |
| Jun 08, 2023 | 4 | Filing |
| Jun 08, 2023 | 4 | Filing |